Disco Pharmaceuticals
Disco Pharmaceuticals is a cancer Surface Protein Identification founded in 2022.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Funding Rounds
Edits on 15 Aug, 2024
Ivo Devereux
Edits made to:
Infobox (+11 properties)
Infobox
Country
Founded Date
2022
Headquarters
Industry
Latest Funding Round Date
January 16, 2024
Latest Funding Round Amount (USD)
22,000,000
Number of Employees (Ranges)
11 – 50
Total Funding Amount (USD)
22,000,000
Edits on 13 Aug, 2024
Golden AI
Edits made to:
Infobox (-3 properties)
Infobox
Latest Funding Round Date
January 16, 2024
Latest Funding Round Amount (USD)
21,738,846
Total Funding Amount (USD)
21,738,846
Edits on 6 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Funding Rounds
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Latest Funding Round Date
January 16, 2024
Latest Funding Round Amount (USD)
21,738,846
Total Funding Amount (USD)
21,738,846
Edits on 16 Feb, 2024
Amy Sar
Edits made to:
Infobox (+2/-1 properties)
Disco Pharmaceuticals
Cancer Surface Protein Identification
Infobox
Email Address
info@discopharma.de?subject=EnquiryfromDISCOwebsite
Email Address
info@discopharma.de?subject=enquiryfromdiscowebsite
Edits on 15 Feb, 2024
Amy Sar
Edits made to:
Infobox (+7 properties)
Description (+37 characters)
Disco Pharmaceuticals
Cancer Surface Protein Identification
Infobox
Industry
Official Website
Location
Twitter URL
Email Address
info@discopharma.de?subject=EnquiryfromDISCOwebsite
Find more companies like Disco Pharmaceuticals
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.